English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Biotech firms emphasize regulatory alignment amid ongoing uncertainty after recent FDA reversals
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Baseline Therapeutics launches phase III trials targeting addiction with GLP-1 drug
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Biopharma leaders express optimism at JPM26 despite absence of major deals
+ Pharmaceuticals
Patient Daily | Jan 26, 2026

Rare disease biotechs face loss if priority review voucher program remains lapsed
+ Pharmaceuticals
Patient Daily | Jan 26, 2026

Five experimental treatments could reshape future care for Parkinson's disease
+ Pharmaceuticals
Patient Daily | Jan 23, 2026

Biogen outlines Alzheimer's expansion plans following Leqembi launch
+ Pharmaceuticals
Patient Daily | Jan 23, 2026

Gilead highlights HIV advances and oncology ambitions at JPM healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 23, 2026

Sanofi CEO sees opportunity for acquisitions amid US vaccine hesitancy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation